Sunday, July 4, 2021

Serum Institute of India, with its production ‘very stressed,’ asks government to help boost production

With its production capacity “very stressed,” the world’s largest producer of vaccines is seeking relief from its government.

The Serum Institute of India has requested a grant of more than $400 million to beef up production of the AstraZeneca COVID-19 vaccine. The investment would allow SII to increase output from around 70 million doses per month to more than 100 million by the end of May.

With India in the throes of a coronavirus surge—reporting more than 100,000 new cases daily—and facing a vaccine shortage, most of the factory’s output has been retained for domestic needs. 

RELATED: U.K. inspects AstraZeneca vaccine partner’s India manufacturing, setting stage for supply boost

In late February, CEO Adar Poonawalla asked the public for patience as SII sought to balance India’s needs with those of the rest of the world. Since then, the government has restricted exports. This week, Poonawalla said the company’s production capacity was “very stressed.” 

The company has supplied roughly 90% of the 90 million vaccine doses administered so far in the country. India has yet to open vaccinations to those under age 45.

RELATED: AstraZeneca vaccine production unscathed after fire breaks out at Serum Institute of India complex

The export pause has also added to the stress of embattled AstraZeneca, which has fallen behind in supplying the worldwide relief effort COVAX. The company has committed 240 million doses to COVAX by the end of June. As of Thursday, less than 39 million had been delivered.

This week, Poonawalla told the Business Standard that AstraZeneca sent a legal notice to SII for delays in supplying the vaccine.

Source link

Stay Connected


Latest Articles

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...